April 21, 2017 / 8:41 PM / 4 months ago

BRIEF-Aclaris Therapeutics says sold 635,000 shares of stock for $31.50/shr

April 21 (Reuters) - Aclaris Therapeutics Inc:

* Aclaris Therapeutics-sold 635,000 shares of its stock at a weighted average price per share of $31.50, for aggregate gross proceeds of about $20.0 million

* Aclaris Therapeutics - shares were sold through Cowen And Company Llc pursuant to a sales agreement with them dated November 2, 2016 - sec filing Source text - bit.ly/2oSfFoU Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below